Wird geladen...
Concomitant KRAS and BRAF mutations in colorectal cancer
BRAF and KRAS are two key oncogenes in the RAS/RAF/MEK/MAP-kinase signaling pathway. While previously considered mutually exclusive, concomitant mutations in both KRAS and BRAF genes have been identified in colorectal cancer (CRC). The clinical outcome of these patients remains undetermined. We pres...
Gespeichert in:
| Veröffentlicht in: | J Gastrointest Oncol |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
AME Publishing Company
2019
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6534722/ https://ncbi.nlm.nih.gov/pubmed/31183211 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jgo.2019.01.10 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|